GOSS
Price
$0.96
Change
-$0.00 (-0.00%)
Updated
Oct 17 closing price
25 days until earnings call
NXTC
Price
$1.45
Change
-$0.00 (-0.00%)
Updated
Oct 17 closing price
13 days until earnings call
Ad is loading...

GOSS vs NXTC

Header iconGOSS vs NXTC Comparison
Open Charts GOSS vs NXTCBanner chart's image
Gossamer Bio
Price$0.96
Change-$0.00 (-0.00%)
Volume$268.29K
CapitalizationN/A
NextCure
Price$1.45
Change-$0.00 (-0.00%)
Volume$13.87K
CapitalizationN/A
View a ticker or compare two or three
GOSS vs NXTC Comparison Chart
Loading...
GOSS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NXTC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
GOSS vs. NXTC commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOSS is a Sell and NXTC is a Sell.

COMPARISON
Comparison
Oct 18, 2024
Stock price -- (GOSS: $0.96 vs. NXTC: $1.45)
Brand notoriety: GOSS and NXTC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GOSS: 32% vs. NXTC: 45%
Market capitalization -- GOSS: $221.27M vs. NXTC: $38.33M
GOSS [@Biotechnology] is valued at $221.27M. NXTC’s [@Biotechnology] market capitalization is $38.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOSS’s FA Score shows that 0 FA rating(s) are green whileNXTC’s FA Score has 1 green FA rating(s).

  • GOSS’s FA Score: 0 green, 5 red.
  • NXTC’s FA Score: 1 green, 4 red.
According to our system of comparison, GOSS is a better buy in the long-term than NXTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOSS’s TA Score shows that 5 TA indicator(s) are bullish while NXTC’s TA Score has 4 bullish TA indicator(s).

  • GOSS’s TA Score: 5 bullish, 6 bearish.
  • NXTC’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, GOSS is a better buy in the short-term than NXTC.

Price Growth

GOSS (@Biotechnology) experienced а -2.16% price change this week, while NXTC (@Biotechnology) price change was +5.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

GOSS is expected to report earnings on Mar 21, 2025.

NXTC is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GOSS($221M) has a higher market cap than NXTC($38.3M). NXTC YTD gains are higher at: 27.193 vs. GOSS (5.479). GOSS (-59.72M) and NXTC (-60.4M) have comparable annual earnings (EBITDA) . GOSS has more cash in the bank: 354M vs. NXTC (86.4M). NXTC has less debt than GOSS: NXTC (5.59M) vs GOSS (199M). GOSS has higher revenues than NXTC: GOSS (95.8M) vs NXTC (0).
GOSSNXTCGOSS / NXTC
Capitalization221M38.3M577%
EBITDA-59.72M-60.4M99%
Gain YTD5.47927.19320%
P/E RatioN/AN/A-
Revenue95.8M0-
Total Cash354M86.4M410%
Total Debt199M5.59M3,560%
TECHNICAL ANALYSIS
Technical Analysis
GOSSNXTC
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 18 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
GOSS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NXTC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL232.150.37
+0.16%
Apple
SPY582.350.05
+0.01%
SPDR® S&P 500® ETF Trust
TSLA220.89-0.44
-0.20%
Tesla
BTC.X67399.836000-212.882810
-0.31%
Bitcoin cryptocurrency
GME21.41-0.25
-1.15%
GameStop Corp

GOSS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOSS has been loosely correlated with MEIP. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GOSS jumps, then MEIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOSS
1D Price
Change %
GOSS100%
-0.77%
MEIP - GOSS
46%
Loosely correlated
-0.72%
CGEM - GOSS
45%
Loosely correlated
-1.36%
SYRE - GOSS
41%
Loosely correlated
+1.20%
APVO - GOSS
41%
Loosely correlated
+3.48%
VIR - GOSS
41%
Loosely correlated
-1.91%
More

NXTC and

Correlation & Price change

A.I.dvisor indicates that over the last year, NXTC has been loosely correlated with CYTK. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if NXTC jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXTC
1D Price
Change %
NXTC100%
-1.36%
CYTK - NXTC
37%
Loosely correlated
-1.36%
FATE - NXTC
35%
Loosely correlated
+0.31%
ORMP - NXTC
33%
Poorly correlated
-1.23%
GOSS - NXTC
32%
Poorly correlated
-0.77%
LYEL - NXTC
30%
Poorly correlated
-5.60%
More